NLRP3 inflammasome as a molecular marker in diabetic cardiomyopathy

Frontiers in Physiology

Volumn 8, Issue JUL, 2017, Pages

  Luo, Beibei ^a   Huang, Feng ^a   Liu, Yanli ^a   Liang, Yiying ^a   Wei, Zhe ^a   Ke, Honghong ^a   Zeng, Zhiyu ^a   Huang, Weiqiang ^a   He, Yan ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Diabetic cardiomyopathy; Inflammation; NLRP3 inflammasome; Pyroptosis; Thioredoxin interacting inhibiting protein

Indexed keywords

CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; MOLECULAR MARKER; REACTIVE OXYGEN METABOLITE; THIOREDOXIN INTERACTING PROTEIN;

CARDIAC MUSCLE CELL; DIABETIC CARDIOMYOPATHY; HEART FIBROBLAST; HUMAN; HYPERGLYCEMIA; MOLECULAR INTERACTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

EID: 85025809100     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2017.00519     Document Type: Review

References (73)

1. Ahmad, F., Chung, Y. W., Tang, Y., Hockman, S. C., Liu, S., Khan, Y., et al. (2016). Phosphodiesterase 3B (PDE3B) regulates NLRP3 inflammasome in adipose tissue. Sci. Rep. 6:28056. doi: 10.1038/srep28056
2. Allen, I. C., Scull, M. A., Moore, C. B., Holl, E. K., McElvania-TeKippe, E., Taxman, D. J., et al. (2009). The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30, 556-565. doi: 10.1016/j.immuni.2009.02.005
3. Apostolakis, S., Vogiatzi, K., Krambovitis, E., and Spandidos, D. A. (2008). IL-1 cytokines in cardiovascular disease: diagnostic, prognostic and therapeutic implications. Cardiovasc. Hematol. Agents Med. Chem. 6, 150-158. doi: 10.2174/187152508783955006
4. Bergsbaken, T., Fink, S. L., and Cookson, B. T. (2009). Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 7, 99-109. doi: 10.1038/nrmicro2070
5. Boaru, S. G., Borkham-Kamphorst, E., Van de Leur, E., Lehnen, E., Liedtke, C., and Weiskirchen, R. (2015). NLRP3 inflammasome expression is driven by NF-κB in cultured hepatocytes. Biochem. Biophys. Res. Commun. 458, 700-706. doi: 10.1016/j.bbrc.2015.02.029
6. Bracey, N. A., Gershkovich, B., Chun, J., Vilaysane, A., Meijndert, H. C., Wright, J. R. Jr., et al. (2014). Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome. J. Biol. Chem. 289, 19571-19584. doi: 10.1074/jbc.M114.550624
7. Braunwald, E. (2008). Biomarkers in heart failure. N. Engl. J. Med. 358, 2148-2159. doi: 10.1056/NEJMra0800239
8. Bryant, C., and Fitzgerald, K. A. (2009). Molecular mechanisms involved in inflammasome activation. Trends Cell Biol. 19, 455-464. doi: 10.1016/j.tcb.2009.06.002
9. Butts, B., Gary, R. A., Dunbar, S. B., and Butler, J. (2015). The importance of NLRP3 inflammasome in heart failure. J. Card. Fail. 21, 586-593. doi: 10.1016/j.cardfail.2015.04.014
10. Coll, N. S., Epple, P., and Dangl, J. L. (2011). Programmed cell death in the plant immune system. Cell Death Differ. 18, 1247-1256. doi: 10.1038/cdd.2011.37
11. Corsini, E., Galbiati, V., Nikitovic, D., and Tsatsakis, A. M. (2013). Role of oxidative stress in chemical allergens induced skin cells activation. Food Chem. Toxicol. 61, 74-81. doi: 10.1016/j.fct.2013.02.038
12. de Zoete, M. R., Palm, N. W., Zhu, S., and Flavell, R. A. (2014). Inflammasomes. Cold Spring Harb. Perspect. Biol. 6:a016287. doi: 10.1101/cshperspect.a016287
13. Ding, J., Wang, K., Liu, W., She, Y., Sun, Q., Shi, J., et al. (2016). Pore-forming activity and structural autoinhibition of the gasdermin family. Nature 535, 111-116. doi: 10.1038/nature18590
14. Donath, M. Y., and Shoelson, S. E. (2011). Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98-107. doi: 10.1038/nri2925
15. Donath, M. Y., Boni-Schnetzler, M., Ellingsgaard, H., Halban, P. A., and Ehses, J. A. (2010). Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends Endocrinol. Metab. 21, 261-267. doi: 10.1016/j.tem.2009.12.010
16. Franchi, L., Munoz-Planillo, R., and Nunez, G. (2012). Sensing and reacting to microbes through the inflammasomes. Nat. Immunol. 13, 325-332. doi: 10.1038/ni.2231
17. Guarda, G., and So, A. (2010). Regulation of inflammasome activity. Immunology 130, 329-336. doi: 10.1111/j.1365-2567.2010.03283.x
18. He, W. T., Wan, H., Hu, L., Chen, P., Wang, X., Huang, Z., et al. (2015). Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. 25, 1285-1298. doi: 10.1038/cr.2015.139
19. Iyer, S. S., He, Q., Janczy, J. R., Elliott, E. I., Zhong, Z., Olivier, A. K., et al. (2013). Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 39, 311-323. doi: 10.1016/j.immuni.2013.08.001
20. Jang, Y., Lee, A. Y., Jeong, S. H., Park, K. H., Paik, M. K., Cho, N. J., et al. (2015). Chlorpyrifos induces NLRP3 inflammasome and pyroptosis/apoptosis via mitochondrial oxidative stress in human keratinocyte HaCaT cells. Toxicology 338, 37-46. doi: 10.1016/j.tox.2015.09.006
21. Janket, S. J., Javaheri, H., Ackerson, L. K., Ayilavarapu, S., and Meurman, J. H. (2015). Oral infections, metabolic inflammation, genetics, and cardiometabolic diseases. J. Dent. Res. 94(9 Suppl.), 119S-127S. doi: 10.1177/0022034515580795
22. Jin, C., and Flavell, R. A. (2013). Innate sensors of pathogen and stress: linking inflammation to obesity. J. Allergy Clin. Immunol. 132, 287-294. doi: 10.1016/j.jaci.2013.06.022
23. Jo, E. K., Kim, J. K., Shin, D. M., and Sasakawa, C. (2016). Molecular mechanisms regulating NLRP3 inflammasome activation. Cell. Mol. Immunol. 13, 148-159. doi: 10.1038/cmi.2015.95
24. Kayagaki, N., Stowe, I. B., Lee, B. L., O'Rourke, K., Anderson, K., Warming, S., et al. (2015). Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526, 666-671. doi: 10.1038/nature15541
25. Kuethe, F., Sigusch, H. H., Bornstein, S. R., Hilbig, K., Kamvissi, V., and Figulla, H. R. (2007). Apoptosis in patients with dilated cardiomyopathy and diabetes: a feature of diabetic cardiomyopathy? Horm. Metab. Res. 39, 672-676. doi: 10.1055/s-2007-985823
26. Kumar, S., Prasad, S., and Sitasawad, S. L. (2013). Multiple antioxidants improve cardiac complications and inhibit cardiac cell death in streptozotocin-induced diabetic rats. PLoS ONE 8:e67009. doi: 10.1371/journal.pone.0067009
27. Lamkanfi, M., and Dixit, V. M. (2014). Mechanisms and functions of inflammasomes. Cell 157, 1013-1022. doi: 10.1016/j.cell.2014.04.007
28. Lebeaupin, C., Proics, E., de Bieville, C. H., Rousseau, D., Bonnafous, S., Patouraux, S., et al. (2015). ER stress induces NLRP3 inflammasome activation and hepatocyte death. Cell Death Dis. 6:e1879. doi: 10.1038/cddis.2015.248
29. Legrand-Poels, S., Esser, N., L'Homme, L., Scheen, A., Paquot, N., and Piette, J. (2014). Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes. Biochem. Pharmacol. 92, 131-141. doi: 10.1016/j.bcp.2014.08.013
30. Lerner, A. G., Upton, J. P., Praveen, P. V., Ghosh, R., Nakagawa, Y., Igbaria, A., et al. (2012). IRE1alpha induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab. 16, 250-264. doi: 10.1016/j.cmet.2012.07.007
31. Liao, P. C., Chao, L. K., Chou, J. C., Dong, W. C., Lin, C. N., Lin, C. Y., et al. (2013). Lipopolysaccharide/adenosine triphosphate-mediated signal transduction in the regulation of NLRP3 protein expression and caspase-1-mediated interleukin-1β secretion. Inflamm. Res. 62, 89-96. doi: 10.1007/s00011-012-0555-2
32. Liu, L., Ding, W. Y., Zhao, J., Wang, Z. H., Zhong, M., Zhang, W., et al. (2013). Activin receptor-like kinase 7 mediates high glucose-induced H9c2 cardiomyoblast apoptosis through activation of Smad2/3. Int. J. Biochem. Cell Biol. 45, 2027-2035. doi: 10.1016/j.biocel.2013.06.018
33. Liu, X., Zhang, Z., Ruan, J., Pan, Y., Magupalli, V. G., Wu, H., et al. (2016). Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature 535, 153-158. doi: 10.1038/nature18629
34. Liu, Y. F., Wen, C. Y., Chen, Z., Wang, Y., Huang, Y., and Tu, S. H. (2016). Effects of berberine on NLRP3 and IL-1β expressions in monocytic THP-1 cells with monosodium urate crystals-induced inflammation. Biomed Res. Int. 2016:2503703. doi: 10.1155/2016/2503703
35. Lopez-Pastrana, J., Ferrer, L. M., Li, Y. F., Xiong, X., Xi, H., Cueto, R., et al. (2015). Inhibition of caspase-1 activation in endothelial cells improves angiogenesis: a novel therapeutic potential for ischemia. J. Biol. Chem. 290, 17485-17494. doi: 10.1074/jbc.M115.641191
36. Loppnow, H., Westphal, E., Buchhorn, R., Wessel, A., and Werdan, K. (2001). Interleukin-1 and related proteins in cardiovascular disease in adults and children. Shock 16(Suppl. 1), 3-9. doi: 10.1097/00024382-200116001-00002
37. Lu, B., Nakamura, T., Inouye, K., Li, J., Tang, Y., Lundback, P., et al. (2012). Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488, 670-674. doi: 10.1038/nature11290
38. Luo, B., Li, B., Wang, W., Liu, X., Liu, X., Xia, Y., et al. (2014a). Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model. Cardiovasc. Drugs Ther. 28, 33-43. doi: 10.1007/s10557-013-6498-1
39. Luo, B., Li, B., Wang, W., Liu, X., Xia, Y., Zhang, C., et al. (2014b). NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model. PLoS ONE 9:e104771. doi: 10.1371/journal.pone.0104771
40. Martinon, F. (2010). Signaling by ROS drives inflammasome activation. Eur. J. Immunol. 40, 616-619. doi: 10.1002/eji.200940168
41. Mastrocola, R., Collino, M., Penna, C., Nigro, D., Chiazza, F., Fracasso, V., et al. (2016a). Maladaptive modulations of NLRP3 inflammasome and cardioprotective pathways are involved in diet-induced exacerbation of myocardial ischemia/reperfusion injury in mice. Oxid. Med. Cell. Longev. 2016:3480637. doi: 10.1155/2016/3480637
42. Mastrocola, R., Penna, C., Tullio, F., Femmino, S., Nigro, D., Chiazza, F., et al. (2016b). Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia/reperfusion injury by activation of RISK and mitochondrial pathways. Oxid. Med. Cell. Longev. 2016:5271251. doi: 10.1155/2016/5271251
43. Miao, E. A., Rajan, J. V., and Aderem, A. (2011). Caspase-1-induced pyroptotic cell death. Immunol. Rev. 243, 206-214. doi: 10.1111/j.1600-065X.2011.01044.x
44. Monack, D. M., Raupach, B., Hromockyj, A. E., and Falkow, S. (1996). Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc. Natl. Acad. Sci. U.S.A. 93, 9833-9838. doi: 10.1073/pnas.93.18.9833
45. Nakahira, K., Haspel, J. A., Rathinam, V. A., Lee, S. J., Dolinay, T., Lam, H. C., et al. (2011). Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol. 12, 222-230. doi: 10.1038/ni.1980
46. Nakayama, M., Simmons, K. M., and Michels, A. W. (2015). Molecular interactions governing autoantigen presentation in type 1 diabetes. Curr. Diab. Rep. 15, 113. doi: 10.1007/s11892-015-0689-z
47. Pandey, A., Chawla, S., and Guchhait, P. (2015). Type-2 diabetes: current understanding and future perspectives. IUBMB Life 67, 506-513. doi: 10.1002/iub.1396
48. Qamar, A., and Rader, D. J. (2012). Effect of interleukin 1β inhibition in cardiovascular disease. Curr. Opin. Lipidol. 23, 548-553. doi: 10.1097/MOL.0b013e328359b0a6
49. Qiao, Y., Wang, P., Qi, J., Zhang, L., and Gao, C. (2012). TLR-induced NF-κB activation regulates NLRP3 expression in murine macrophages. FEBS Lett. 586, 1022-1026. doi: 10.1016/j.febslet.2012.02.045
50. Rajamaki, K., Mayranpaa, M. I., Risco, A., Tuimala, J., Nurmi, K., Cuenda, A., et al. (2016). p38delta MAPK: a novel regulator of NLRP3 inflammasome activation with increased expression in coronary atherogenesis. Arterioscler. Thromb. Vasc. Biol. 36, 1937-1946. doi: 10.1161/ATVBAHA.115.307312
51. Robbins, G. R., Wen, H., and Ting, J. P. (2014). Inflammasomes and metabolic disorders: old genes in modern diseases. Mol. Cell 54, 297-308. doi: 10.1016/j.molcel.2014.03.029
52. Santiago, J. J., McNaughton, L. J., Koleini, N., Ma, X., Bestvater, B., Nickel, B. E., et al. (2014). High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodeling. PLoS ONE 9:e97281. doi: 10.1371/journal.pone.0097281
53. Schroder, K., Zhou, R., and Tschopp, J. (2010). The NLRP3 inflammasome: a sensor for metabolic danger? Science 327, 296-300. doi: 10.1126/science.1184003
54. Shalini, S., Dorstyn, L., Dawar, S., and Kumar, S. (2015). Old, new and emerging functions of caspases. Cell Death Differ. 22, 526-539. doi: 10.1038/cdd.2014.216
55. Shao, B. Z., Xu, Z. Q., Han, B. Z., Su, D. F., and Liu, C. (2015). NLRP3 inflammasome and its inhibitors: a review. Front. Pharmacol. 6:262. doi: 10.3389/fphar.2015.00262
56. Shaw, J. E., Sicree, R. A., and Zimmet, P. Z. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87, 4-14. doi: 10.1016/j.diabres.2009.10.007
57. Shenoy, A. R., Wellington, D. A., Kumar, P., Kassa, H., Booth, C. J., Cresswell, P., et al. (2012). GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals. Science 336, 481-485. doi: 10.1126/science.1217141
58. Shi, H., Zhang, Z., Wang, X., Li, R., Hou, W., Bi, W., et al. (2015). Inhibition of autophagy induces IL-1β release from ARPE-19 cells via ROS mediated NLRP3 inflammasome activation under high glucose stress. Biochem. Biophys. Res. Commun. 463, 1071-1076. doi: 10.1016/j.bbrc.2015.06.060
59. Shi, J., Gao, W., and Shao, F. (2017). Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem. Sci. 42, 245-254. doi: 10.1016/j.tibs.2016.10.004
60. Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., et al. (2015). Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660-665. doi: 10.1038/nature15514
61. Singh, L. P. (2014). The NLRP3 inflammasome and diabetic cardiomyopathy: editorial to: "Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model" by Beibei Luo et al. Cardiovasc. Drugs Ther. 28, 5-6. doi: 10.1007/s10557-013-6501-x
62. Somanna, N. K., Yariswamy, M., Garagliano, J. M., Siebenlist, U., Mummidi, S., Valente, A. J., et al. (2015). Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2. Cell. Signal. 27, 1928-1938. doi: 10.1016/j.cellsig.2015.07.001
63. Vandanmagsar, B., Youm, Y. H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., et al. (2011). The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179-188. doi: 10.1038/nm.2279
64. Wang, R., Wang, Y., Mu, N., Lou, X., Li, W., Chen, Y., et al. (2017). Activation of NLRP3 inflammasomes contributes to hyperhomocysteinemia-aggravated inflammation and atherosclerosis in apoE-deficient mice. Lab. Invest. doi: 10.1038/labinvest.2017.30. [Epub ahead of print].
65. Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T., et al. (2011). Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12, 408-415. doi: 10.1038/ni.2022
66. Westermeier, F., Navarro-Marquez, M., Lopez-Crisosto, C., Bravo-Sagua, R., Quiroga, C., Bustamante, M., et al. (2015). Defective insulin signaling and mitochondrial dynamics in diabetic cardiomyopathy. Biochim. Biophys. Acta 1853, 1113-1118. doi: 10.1016/j.bbamcr.2015.02.005
67. Wolf, P., Winhofer, Y., Krssak, M., Smajis, S., Harreiter, J., Kosi-Trebotic, L., et al. (2016). Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes. Nutr. Metab. Cardiovasc. Dis. 26, 387-392. doi: 10.1016/j.numecd.2016.03.012
68. Wree, A., Eguchi, A., McGeough, M. D., Pena, C. A., Johnson, C. D., Canbay, A., et al. (2014). NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 59, 898-910. doi: 10.1002/hep.26592
69. Zhang, W., Xu, X., Kao, R., Mele, T., Kvietys, P., Martin, C. M., et al. (2014). Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activation. PLoS ONE 9:e107639. doi: 10.1371/journal.pone.0107639
70. Zhou, R., Tardivel, A., Thorens, B., Choi, I., and Tschopp, J. (2010). Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136-140. doi: 10.1038/ni.1831
71. Zlobine, I., Gopal, K., and Ussher, J. R. (2016). Lipotoxicity in obesity and diabetes-related cardiac dysfunction. Biochim. Biophys. Acta 1861, 1555-1568. doi: 10.1016/j.bbalip.2016.02.011
72. Zu, Y., Wan, L. J., Cui, S. Y., Gong, Y. P., and Li, C. L. (2015). The mitochondrial Na+/Ca2+ exchanger may reduce high glucose-induced oxidative stress and nucleotide-binding oligomerization domain receptor 3 inflammasome activation in endothelial cells. J. Geriatr. Cardiol. 12, 270-278. doi: 10.11909/j.issn.1671-5411.2015.03.003
73. Zychlinsky, A., Prevost, M. C., and Sansonetti, P. J. (1992). Shigella flexneri induces apoptosis in infected macrophages. Nature 358, 167-169. doi: 10.1038/358167a0